ALK and non-small cell lung carcinoma: The biological potential of heterocycles possessing β-amino acid motifs also has found application in searching for new anaplastic lymphoma kinase (ALK) inhibitors for the treatment of non–small-cell lung cancer (NSCLC) [26].